Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The prevalence of pulmonary hypertension in adults with sickle cell disease, the mechanism of its development, and its prospective prognostic significance are unknown. METHODS: We performed Doppler echocardiographic assessments of pulmonary-artery systolic pressure in 195 consecutive patients (82 men and 113 women; mean [+/-SD] age, 36+/-12 years). Pulmonary hypertension was prospectively defined as a tricuspid regurgitant jet velocity of at least 2.5 m per second. Patients were followed for a mean of 18 months, and data were censored at the time of death or loss to follow-up. RESULTS: Doppler-defined pulmonary hypertension occurred in 32 percent of patients. Multiple logistic-regression analysis, with the use of the dichotomous variable of a tricuspid regurgitant jet velocity of less than 2.5 m per second or 2.5 m per second or more, identified a self-reported history of cardiovascular or renal complications, increased systolic blood pressure, high lactate dehydrogenase levels (a marker of hemolysis), high levels of alkaline phosphatase, and low transferrin levels as significant independent correlates of pulmonary hypertension. The fetal hemoglobin level, white-cell count, and platelet count and the use of hydroxyurea therapy were unrelated to pulmonary hypertension. A tricuspid regurgitant jet velocity of at least 2.5 m per second, as compared with a velocity of less than 2.5 m per second, was strongly associated with an increased risk of death (rate ratio, 10.1; 95 percent confidence interval, 2.2 to 47.0; P<0.001) and remained so after adjustment for other possible risk factors in a proportional-hazards regression model. CONCLUSIONS: Pulmonary hypertension, diagnosed by Doppler echocardiography, is common in adults with sickle cell disease. It appears to be a complication of chronic hemolysis, is resistant to hydroxyurea therapy, and confers a high risk of death. Therapeutic trials targeting this population of patients are indicated.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Patients with higher rates of hemolysis have lower steady-state Hb levels and are more likely to develop vascular injury and organ dysfunction as they age, manifesting as pulmonary hypertension, diastolic left heart disease, and renal dysfunction (proteinuria, albuminuria, and chronic kidney dysfunction) (62, 64, 65, 70, 79).”
From Pathophysiology of Sickle Cell Disease (2019) · cites this paper as [64]
Citations
Cites
Recommendations for Quantitation of the Left Ventricle by Two-Dimensional Echocardiography
Schiller, N. B., Shah, P. M., Crawford, M., DeMaria, A., Devereux, R., Feigenbaum, H., Gutgesell, H., Reichek, N., Sahn, D., Schnittger, I., et al. (1989) · Journal of the American Society of Echocardiography · doi:10.1016/s0894-7317(89)80014-8 · Cited by 8,121
Mortality in sickle cell disease. Life expectancy and risk factors for early death
Platt, O. S., Brambilla, D. J., Rosse, W. F., Milner, P. F., Castro, O., Steinberg, M. H., & Klug, P. P. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406093302303 · Cited by 3,320
Self-citationQuiñones, M. A., Otto, C. M., Stoddard, M., Waggoner, A., & Zoghbi, W. A. (2002) · Journal of the American Society of Echocardiography · doi:10.1067/mje.2002.120202 · Cited by 2,130
Adams, R. J., McKie, V. C., Hsu, L., Files, B., Vichinsky, E., Pegelow, C., Abboud, M., Gallagher, D., Kutlar, A., Nichols, F. T., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807023390102 · Cited by 1,866
De Caterina, R., Libby, P., Peng, H. B., Thannickal, V. J., Rajavashisth, T. B., Gimbrone, M. A., Shin, W. S., & Liao, J. K. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118074 · Cited by 1,782
Primary Pulmonary Hypertension
Rubin, L. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701093360207 · Cited by 1,726
Cerebrovascular accidents in sickle cell disease: rates and risk factors.
(1998) · PubMed · doi:10.1182/blood.v91.1.288 · Cited by 1,694
Dams, R. O. J. A., Ie, V. I. C. M. C. K., Su, L. E. H., Iles, B. E. F., Ichinsky, E. L. V., Egelow, C. H. P., Bboud, M. I. A., Allagher, D. I. G., Utlar, K., Ichols, F. E. T. N., et al. (2015) · Cited by 1,338
Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
Reiter, C. D., Wang, X., Tanus-Santos, J. E., Hogg, N., Cannon, R. O., Schechter, A. N., & Gladwin, M. T. (2002) · Nature Medicine · doi:10.1038/nm1202-799 · Cited by 1,330
Self-citationCell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
Reiter, C. D., Wang, X., Tanus-Santos, J. E., et al. (2002) · Nature Medicine · doi:10.1038/nm799 · Cited by 1,097
Cited by
Items 901–999 of 999
Sickle cell disease, pulmonary hypertension, and sarcoidosis
Lehmann, L., Riess, H. B., & Sturm, I. (2008) · Annals of Hematology · doi:10.1007/s00277-008-0437-4 · Cited by 5
Saunthararajah, Y., & Vichinsky, E. P. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35762-3.00042-1 · Cited by 8
Machado, R. F., & Castro, O. L. (2007) · Advances in Pulmonary Hypertension · doi:10.21693/1933-088x-6.1.16 · Cited by 5
Self-citationMcMahon, C. (2006) · Wiley eBooks · doi:10.1002/9780470987001.ch10 · Cited by 5
Cord blood transplantation for sickle cell anemia: Bust or boom?
Walters, M. C. (2007) · Pediatric Transplantation · doi:10.1111/j.1399-3046.2007.00757.x · Cited by 6
Cho, G., & Hambleton, I. R. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008360 · Cited by 5
Ilonze, C., Rai, P., Galadanci, N. A., Zahr, R. S., Okhomina, V. I., Kang, G., Padmanabhan, D. S., Lebensburger, J. D., & Alishlash, A. S. (2024) · Pediatric Blood & Cancer · doi:10.1002/pbc.31002 · Cited by 4
Novel clinical care models for patients with sickle cell disease
Bartolucci, P. (2024) · Hematology · doi:10.1182/hematology.2024000586 · Cited by 6
Jamwal, S., Calhoun, C. L., Mohanty, S., Montgomery, R. R., Krishnamurti, L., Shaw, A. C., & Yildirim, I. B. (2025) · Immunology · doi:10.1111/imm.70080 · Cited by 6
Pathophysiology of Pulmonary Arterial Hypertension
Farber, H. W. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-075-5_4 · Cited by 6
Abid, S., Kebe, K., Houssaïni, A., Tomberli, F., Marcos, É., Bizard, E., Breau, M., Parpaleix, A., Tissot, C.-M., Maître, B., et al. (2018) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000570 · Cited by 4
Musa, B. M., Odoh, C., Galadanci, N. A., Saidu, H., & Aliyu, M. H. (2017) · International Health · doi:10.1093/inthealth/ihx074 · Cited by 4
Deveci, O. S., Özmen, Ç., Karaaslan, M. B., Çelik, A. İ., Rahimova, H., Akray, A., Tepe, Ö., Gürkan, E., & Deniz, A. (2021) · Medical Principles and Practice · doi:10.1159/000521216 · Cited by 4
Delicou, S. (2016) · Hematology & Transfusion International Journal · doi:10.15406/htij.2016.02.00042 · Cited by 4
Multiparametric Cardiac Magnetic Resonance Assessment in Sickle Beta Thalassemia
Pistoia, L., Meloni, A., Positano, V., Longo, F., Borsellino, Z., Spasiano, A., Righi, R., Renne, S., Izzo, D., Savino, K., et al. (2024) · Diagnostics · doi:10.3390/diagnostics14070691 · Cited by 4
Gene-environmental influence of space and microgravity on red blood cells with sickle cell disease
Igbineweka, N. E., & van Loon, J. J. W. A. (2024) · npj Genomic Medicine · doi:10.1038/s41525-024-00427-7 · Cited by 7
Pulmonary hypertension: Classification and treatment
Channick, R. N. (2010) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(10)71067-9 · Cited by 3
Saudi guidelines on diagnosis and treatment of pulmonary arterial hypertension
Idrees, M. M., Al-Hajjaj, M. S., Khan, J., Hazmi, M. A., Alanezi, M. O., Saleemi, S., Sanai, F. M., Kashour, T. S., Wali, S., & Barst, R. J. (2008) · Annals of Thoracic Medicine · doi:10.4103/1817-1737.39589 · Cited by 14
Role of iloprost and bosentan in pulmonary arterial hypertension
Saleh, J.-E. A. (2008) · Nigerian Journal of Medicine · doi:10.4314/njm.v17i1.37347 · Cited by 4
Fukui, W., Kaneko, M., Sakuma, S., Kawahara, T., & Arai, F. (2012) · Proceedings - IEEE International Conference on Robotics and Automation/Proceedings · doi:10.1109/icra.2012.6224856 · Cited by 4
Prävention von Infektionen und Thrombosen nach Splenektomie oder funktioneller Asplenie
Eber, S., Germing, U., Heimpel, H., Kern, W., Schmugge, M., & Engelhardt, M. M. (2013) · Kinder- und Jugendmedizin · doi:10.1055/s-0038-1629332 · Cited by 4
HIV-1 infection in sickle cell disease and sickle cell trait: role of iron and innate response
Nekhai, S. A., & Kumari, N. (2022) · Expert Review of Hematology · doi:10.1080/17474086.2022.2054799 · Cited by 7
Evaluation of cardiac sequelae in patients with sickle cell anemia.
Amoozgar, H., Dastgheib, L., Seifi, V., & Karimi, M. (2015) · PubMed · Cited by 4
Pulmonale Hypertonie: mikroRNAs in Pathogenese, Diagnostik und Therapie
Huber, L. C., Leuenberger, C., Kohler, M., & Brock, M. (2014) · Pneumologie · doi:10.1055/s-0034-1365456 · Cited by 4
Die Bedeutung der Hämolyse in Anästhesie und Intensivmedizin
Graw, J. A., Baron, D. M., & Francis, R. C. E. (2018) · AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie · doi:10.1055/s-0043-121622 · Cited by 7
Kelly, S. J., Singhal, S., Elwing, J., & Shizukuda, Y. (2010) · Echocardiography · doi:10.1111/j.1540-8175.2010.01168.x · Cited by 4
Self-citationCita, K.-C., Ferdinand, S., Connes, P., Brudey, L., Tressières, B., Etienne‐Julan, M., Lemonne, N., Tarer, V., Élion, J., & Romana, M. (2016) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2016.02.006 · Cited by 4
Transfusion of the Hemoglobinopathy Patient
Hillyer, K. L., & Eckman, J. R. (2007) · Elsevier eBooks · doi:10.1016/b978-0-443-06981-9.50043-0 · Cited by 4
Howard, J., & Davies, S. C. (2007) · Paediatrics and Child Health · doi:10.1016/j.paed.2007.05.001 · Cited by 8
Oldham, M., Conrey, A. K., Pittman, C. A., Fisher, C., Hargrett, S., West, K. A., Jackson, M., Martin, S. C., Hsieh, M. M., Jeffries, N. O., et al. (2020) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1699 · Cited by 4
Hemoglobin SC Disease and Hemoglobin C Disorders
Steinberg, M. H., & Nagel, R. L. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511596582.029 · Cited by 9
Unraveling restrictive chronic lung disease in sickle cell disease [Editorial]
Jain, S., Gladwin, M. T., & Novelli, E. M. (2013) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.13.0509 · Cited by 4
Self-citationSymptomatic Pulmonary Hypertension in a Child with Sickle Cell Disease
Villavicencio, K. L., Ivy, D. D., Cole, L., & Nuss, R. (2008) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2008.01.042 · Cited by 4
Purine-Rich Foods and the Risk of Gout in Men
Dohan, J. L. (2004) · New England Journal of Medicine · doi:10.1056/nejm200406103502417 · Cited by 4
John, T. D., Walters, M. C., Rangarajan, H. G., Rahim, M. Q., McKinney, C. M., Bollard, C. M., Abusin, G. A., Eapen, M., Kassim, A. A., & DeBaun, M. R. (2024) · Blood Advances · doi:10.1182/bloodadvances.2024014078 · Cited by 4
Swarray‐Deen, A., Adana, M. Y., Alao, M. A., Agyen-Frimpong, V. A., Fakunle, A. G., Alangea, D. O., Adjei, D. N., Yeboah, K., Raji, Y. R., Oppong, S. A., et al. (2024) · AJOG Global Reports · doi:10.1016/j.xagr.2024.100413 · Cited by 3
Gomaa, D. A., El-Haggar, S. M., El-Shanshory, M. R., Razaky, O. E., & El‐Afify, D. (2025) · Pediatric Drugs · doi:10.1007/s40272-025-00701-w · Cited by 4
A practical approach to vascular pathology in pulmonary hypertension
Grünberg, K., & Mooi, W. J. (2013) · Diagnostic histopathology · doi:10.1016/j.mpdhp.2013.06.013 · Cited by 3
Firth, P. G., & Kinane, T. B. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-42974-0.00013-6 · Cited by 3
Cardiac causes of hypoxia in sickle cell disease
Noronha, S. A. (2020) · Progress in Pediatric Cardiology · doi:10.1016/j.ppedcard.2019.101192 · Cited by 8
Resende, M. B. S., Ferrari, T. C. A., de Araújo, C. G., Vasconcelos, M. C. M., Tupinambás, J. T., Dias, R. C. T. M., Barros, F. C., Januário, J. N., Barbosa, M. M., & Nunes, M. C. P. (2020) · International journal of cardiac imaging · doi:10.1007/s10554-020-01924-3 · Cited by 4
Early recognition of pulmonary complications of sickle cell disease
Almusally, R. M. (2023) · Saudi Medical Journal · doi:10.15537/smj.2023.44.1.20220636 · Cited by 3
“Severity” in adult sickle cell disease
Steinberg, M. H., & Gladwin, M. T. (2023) · American Journal of Hematology · doi:10.1002/ajh.27024 · Cited by 4
Self-citationCardiovascular complications of sickle cell disease: A primer for the general clinician
Ilonze, C., Echefu, G. C., Broadnax, A., Johnson, A. E., Etuk, A., & Ilonze, O. J. (2023) · Journal of the National Medical Association · doi:10.1016/j.jnma.2023.11.010 · Cited by 3
Mkwambe, M. C., Deng, Y., & Dongchi, Z. (2024) · International Journal of Clinical Medicine · doi:10.4236/ijcm.2024.151001 · Cited by 6
Mendonça-Reis, E., Guimarães-Nobre, C. C., Teixeira-Alves, L. R., Miranda‐Alves, L., & Junior, C. B. (2024) · Anemia · doi:10.1155/2024/7924015 · Cited by 3
Roger, G., Denormandie, P., Gobé, T., Azzolina, D., Pham, T. O., Chantalat, C., Cuveillier, D., Bouchachi, A., Patrick Jourdain, M., Lai, C., et al. (2024) · British Journal of Haematology · doi:10.1111/bjh.19394 · Cited by 3
Haemolytic Anaemia-Related Pulmonary Hypertension
Karyofyllis, P., Demerouti, E., Tsetika, E.-G., Apostolopoulou, S., Tsiapras, P. D., Iakovou, I. P., & Tsiapras, D. P. (2024) · Life · doi:10.3390/life14070876 · Cited by 3
Problèmes cliniques émergents chez l’adulte drépanocytaire
Girot, R., Stankovic, K., & Lionnet, F. (2008) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)32689-5 · Cited by 5
Elbarbary, N. S., Ismail, E. A. R., Roushdy, A. M., & Fahmy, E. (2015) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2015.11.001 · Cited by 3
Anemia in the Patient with Chronic Lung Disease
McMahon, T., & Prybylowski, A. (2017) · Springer eBooks · doi:10.1007/978-1-4939-7360-6_8 · Cited by 3
Decreased Heart Rate Variability in Sickle Cell Anemia as Effect of Pulmonary Arterial Hypertension
Akgül, F., Ta, B., Dv, F., Seyfeli, E., Arystan, A. G., Seydaliyeva, T., Gali, E., Yalçın, F., & Сидоренко, Б. А. (2019) · Kardiologiia · doi:10.18087/cardio.2019.4.10237 · Cited by 4
Eculizumab in the Treatment of Paroxysmal Nocturnal Hemoglobinuria
Hill, A. (2009) · Clinical Medicine Therapeutics · doi:10.4137/cmt.s1939 · Cited by 3
Pulmonary artery segmentation and quantification in sickle cell associated pulmonary hypertension
Linguraru, M. G., Mukherjee, N., Uitert, R. L. V., Summers, R. M., Gladwin, M. T., Machado, R. F., & Wood, B. J. (2008) · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · doi:10.1117/12.770485 · Cited by 3
Self-citationInukai, T., Zhang, X., Kameyama, T., Suzuki, Y., Yoshikawa, K., Kuroda, I., Nemoto, A., Akahane, K., Sato, H., Goi, K., et al. (2010) · American Journal of Hematology · doi:10.1002/ajh.21738 · Cited by 3
Hematopoietic stem cell transplantation: ASBMT/CIBMTR 2010 tandem meeting highlights and discussion
Frey, N. V., & Porter, D. L. (2010) · American Journal of Hematology · doi:10.1002/ajh.21744 · Cited by 3
Improvement of Cardiac Function in Thalassemia Patients Using Deferiprone
Peng, C., Tsai, C. H., Wu, K., Hsu, C.-C., & Sheng, T.-Y. (2007) · Tzu Chi Medical Journal · doi:10.1016/s1016-3190(10)60016-x · Cited by 3
Atichartakarn, V., Chuncharunee, S., Yamwong, S., Yingchoncharoen, T., Jongjirasiri, S., Archararit, N., & Udomsubpayakul, U. (2013) · Acta Haematologica · doi:10.1159/000350644 · Cited by 3
Pulmonary Complications of Sickle Cell Diseases: The Acute Chest Syndrome
Johnson, C. (2005) · Lung biology in health and disease · doi:10.1201/b14118-22 · Cited by 3
Clinical and Laboratory Predictors of Elevated TRV In Sickle Cell Anaemia
Afriyie-Mensah, J. S., Dei-Adomakoh, Y. A., Forson, A. G., Adadey, M., Ndanu, T. A., & Acquaye, J. K. (2018) · Journal of Hematology and Oncology Research · doi:10.14302/issn.2372-6601.jhor-18-2139 · Cited by 2
Afifi, R. A.-R. A.-A., Sedky, Y., Abd-ELKareem, H., & Botros, S. K. A. (2019) · International Journal of Hematology-Oncology and Stem Cell Research · doi:10.18502/ijhoscr.v13i1.323 · Cited by 3
Kueviakoe, M. D. I., Padaro, E., Magnang, H., Mawussi, K., Womey, K. M. C., Layibo, Y., Agbétiafa, K., Koudokpo, A. D. N., & Vovor, A. (2019) · European Scientific Journal ESJ · doi:10.19044/esj.2019.v15n12p318 · Cited by 7
CORRIN, B., & Nicholson, A. G. (2011) · Elsevier eBooks · doi:10.1016/b978-0-7020-3369-8.00008-2 · Cited by 3
Identifying adolescent and young adult patients with sickle cell disease at highest risk of death
Gladwin, M. T., Kato, G. J., & Gordeuk, V. R. (2020) · American Journal of Hematology · doi:10.1002/ajh.26035 · Cited by 4
Self-citationAutrefois, le commerce du livre
Galarneau, C. (1986) · Érudit (Université de Montréal) · Cited by 3
Haematological Diseases in the Tropics
Thachil, J. V., Mbanya, D., & Bates, I. (2023) · Elsevier eBooks · doi:10.1016/b978-0-7020-7959-7.00069-5 · Cited by 4
Sickle Cell Trait Counseling for Student Athletes
Costanzo, V. L. (2011) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 4
Pulmonary Hypertension in HIV-Infected Individuals
Hsue, P. Y., Bolger, A. F., & Martin, J. N. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir277 · Cited by 3
Sickle cell anemia pathophysiology: Back to the data
Eckman, J. R., & Embury, S. H. (2010) · American Journal of Hematology · doi:10.1002/ajh.21967 · Cited by 3
Gladwin, M. T., Kato, G. J., & Machado, R. F. (2025) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202509-2289ed · Cited by 4
Self-citationPrevalence of pulmonary hypertension in children with sickle cell disease
Patel, P., Sharma, S. P., Shah, N., & Manglani, M. V. (2016) · International Journal of Contemporary Pediatrics · doi:10.18203/2349-3291.ijcp20162394 · Cited by 3
Pulmonary Hypertension and Left Ventricular Geometric Types in Sickle Cell Anemia
Oni, O. O., Odeyemi, A. O., Olasinde, Y. T., Odeyemi, A. O., Olufemi-Aworinde, K. J., Abolarin, A. T., & Ala, O. A. (2023) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2023.06.100 · Cited by 6
The Mortality of Adults With Sickle Cell Disease at a Comprehensive Sickle Cell Center
Afranie‐Sakyi, J. A., Randall, E., Fasano, R. M., McLemore, M. L., & Rassi, F. A. E. (2025) · European Journal Of Haematology · doi:10.1111/ejh.14360 · Cited by 2
Ghazaiean, M., Darvishi‐Khezri, H., Najafi, B., Karami, H., & Kosaryan, M. (2025) · PLoS ONE · doi:10.1371/journal.pone.0318751 · Cited by 4
Pharmacological Therapies in Paroxysmal Nocturnal Haemoglobinuria: Focus on Complement Inhibition
Kelly, R. J., Holt, M., & Szer, J. (2025) · Drugs · doi:10.1007/s40265-025-02235-4 · Cited by 7
Exploring Affordable Curative Therapy for Sickle Cell Disease in Africa: A Comprehensive Overview
Kassim, A. A., Thompson, A. A., & Malik, P. (2026) · American Journal of Hematology · doi:10.1002/ajh.70221 · Cited by 2
Bradach, D., Calderón-Salavarría, K., Diaz‐Arribasplata, S., Almahdi, R. S. I., Mavus, N. B., Sangaraju, S. L., Sam, A. A., Mohamed, M. S., Brutus, C., Poojary, P. S., et al. (2026) · European Journal Of Haematology · doi:10.1111/ejh.70206 · Cited by 2
PATHOPHYSIOLOGY OF HEMOGLOBIN AND ITS DISORDERS
Steinberg, M. H. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511596582.012 · Cited by 3
Chronic Pulmonary Hypertension
Ivy, D. D., & Rashid, A. (2009) · Springer eBooks · doi:10.1007/978-1-84882-262-7_45 · Cited by 2
Pulmonary Complications and Lung Function Abnormalities in Children with Sickle Cell Disease
Greenough, A. (2016) · InTech eBooks · doi:10.5772/64365 · Cited by 1
Assessing the atria in pediatric sickle cell disease: Beyond the dilation
Loar, R. W., George, A., Varghese, N. P., Liu, A. M., Colquitt, J. L., & Pignatelli, R. H. (2020) · Echocardiography · doi:10.1111/echo.14956 · Cited by 2
Simonson, J. L., Pandya, D., Kang, J., Talwar, A., & Zaidi, G. Z. (2021) · Pulmonary Circulation · doi:10.1177/20458940211018345 · Cited by 2
Odeyemi, A. O., Olufemi-Aworinde, K. J., Odeyemi, A. O., Oni, O. O., Olasinde, Y. T., & Akande, J. O. (2022) · Alexandria Journal of Medicine · doi:10.1080/20905068.2022.2057146 · Cited by 2
Giray, D., Ünal, S., Demetgül, H., Karpuz, D., & Hallıoğlu, O. (2022) · Journal of diagnostic medical sonography · doi:10.1177/87564793221138581 · Cited by 2
Wilson, S. (2023) · The Hematologist · doi:10.1182/hem.v20.5.202351 · Cited by 2
Joye, R., Wacker, J., Nguyen, D.-A., Hachulla, A.-L., Maggio, A. B. R., Cimasoni, L., Lador, F., Ansari, M., & Beghetti, M. (2023) · Frontiers in Pediatrics · doi:10.3389/fped.2023.1221977 · Cited by 2
Pulmonary Complications of Sickle Cell Disease
Cohen, R. T. (2023) · American Academy of PediatricsItasca, IL eBooks · doi:10.1542/9781610026536-51 · Cited by 2
Sickle Cell Disease Related Vasculopathies and Early Evaluation in a Pediatric Population
Panosyan, D. E., Panosyan, W. S., Corral, I. P., Hanudel, M. R., Pak, Y., & Gotesman, M. (2024) · In Vivo · doi:10.21873/invivo.13556 · Cited by 3
Ramani, G. V., Edelman, K., & López‐Candales, A. (2007) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.08.099 · Cited by 2
Jajamovich, G. H., Pamulapati, V., Alam, S., Mehari, A., Kato, G. J., Wood, B. J., & Linguraru, M. G. (2012) · IEEE International Symposium on Biomedical Imaging (ISBI) · doi:10.1109/isbi.2012.6235679 · Cited by 2
Aspects écho-cardiographiques au cours de la drépanocytose en Guadeloupe
Ondze-Kafata, L. I., Sanouiller, A., Hédreville, M., Hedreville, S., & Larifla, L. (2014) · Pan African Medical Journal · doi:10.11604/pamj.2014.18.45.3820 · Cited by 2
de Groote, P., Lamblin, N., Launay, D., Bervar, J.-F., & HACHULLA, E. (2010) · La Presse Médicale · doi:10.1016/s0755-4982(10)70003-8 · Cited by 2
Complicaciones cardiopulmonares en anemia de células falciformes
Rojas-Jiménez, S., Valle, J. S. L., & Yabur-Espítia, M. (2013) · Archivos de cardiología de México · doi:10.1016/j.acmx.2013.05.003 · Cited by 8
Colombatti, R., Varotto, E., Ricato, S., Nardo, D., Maschietto, N., Teso, S., Pillon, M., Messina, C., Milanesi, O., & Sainati, L. (2011) · Hematology Reports · doi:10.4081/hr.2011.e12 · Cited by 2
ATS Core Curriculum 2016: Part III. Pediatric Pulmonary Medicine
Boyer, D. M., Thomson, C. C., Cohen, R. T., Rao, D., Dell, S., Rayment, J. H., Wang, R., Dy, F. J., Wambach, J., Tam‐Williams, J. B., et al. (2016) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201602-097cme · Cited by 2
Elzubeir, A. M., & Mohamed, B. A. (2013) · International Journal of Multidisciplinary and Current Research · Cited by 2
Atteintes cardiaques au cours de la drépanocytose
Michel, M. (2007) · Archives des Maladies du Coeur et des Vaisseaux - Pratique · doi:10.1016/s1261-694x(07)78548-6 · Cited by 2
Pulmonary Hypertension in Non-Pulmonary Arterial Hypertension Patients
Maron, B. A., & Loscalzo, J. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-2930-6.00057-4 · Cited by 2
Pulmonary Disease in the Pediatric Patient with Acquired Immunodeficiency States
Spahr, J. E., Weiner, D. J., Stokes, D. C., & Kurland, G. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1984-0.00062-0 · Cited by 2
Metadata
- Authors
- Gladwin, M. T., Sachdev, V., Jison, M. L., Shizukuda, Y., Plehn, J. F., Minter, K., Brown, B., Coles, W. A., Nichols, J. S., Ernst, I., Hunter, L. A., Blackwelder, W. C., Schechter, A. N., Rodgers, G. P., Castro, O., & Ognibene, F. P.
- Affiliations
- National Institutes of Health (US)
- National Heart, Lung, and Blood Institute (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-02-26
- Volume
- 350
- Issue
- 9
- Pages
- 886-895
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2148547093
- Cited by
- 1,325
- References
- 42
- Citations by year
- 2026: 42 · 2025: 30 · 2024: 45 · 2023: 44 · 2022: 42 · 2021: 47 · 2020: 34 · 2019: 61 · 2018: 43 · 2017: 57 · 2016: 74 · 2015: 64 · 2014: 76 · 2013: 64 · 2012: 68
- FWCI
- 35.46
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Digital Howard (Howard University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Keywords
- pulmonary hypertension, sickle cell disease, mortality risk, tricuspid regurgitation velocity, Doppler echocardiography, chronic hemolysis, hydroxyurea therapy, risk factors, alkaline phosphatase, lactate dehydrogenase, transferrin, cardiovascular complications, renal complications
- MeSH terms
- Adult, Anemia, Sickle Cell, Antisickling Agents, Blood Pressure, Cause of Death, Drug Resistance, Female, Hemolysis, Humans, Hydroxyurea, Hypertension, Pulmonary, Male, Pulmonary Artery, Risk Factors, Tricuspid Valve Insufficiency, Echocardiography, Doppler, Prevalence, Survival Rate, Logistic Models, Ventricular Function
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.